US Treasury's Office of Foreign Assets Control announced settlement agreements with two different companies. First, HyperBranch Medical Technology, Inc. agreed to a US$107,691.30 settlement for apparent violations of the Iranian Transactions and Sanctions Regulations. Second, Alcon Laboratories, Inc., Alcon Pharmaceuticals Ltd. and Alcon Management, SA, Settle Potential Civil Liability agreed to a US$7.6 million settlement for apparent violations of the Iranian Transactions and Sanctions Regulations and the Sudanese Sanctions Regulations.